(Q31729438)

English

Herbs and atherosclerosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

1 reference

Europe PubMed Central

Herbs and atherosclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Heber D

1

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Current Atherosclerosis Reports

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

93-96

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid-lowering therapy in low-risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11123854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.852

Identifiers

10.1007/S11883-001-0016-9

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31729438&oldid=2195117130"